POSTER SESSION V
Wednesday, March 2, 2011 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
64
CRP Expression in Prostatic Adenocarcinoma.
(738)
S Ali, E Chastain, Q Yin-Goen, AN Young, AO Osunkoya - Emory University School of Medicine, Atlanta
ALDH1A1 as a Marker of Stem Cells in Prostate Cancer: Correlation with Gleason Scores & Tumor Stage and Relevance for Patient Outcome.
(761)
R Bremer, D Tacha - Biocare Medical, LLC, Concord, CA
MMSET Is Associated with Prostate Cancer Progression and Over-Expressed in Androgen Independent Metastatic Prostate Cancer.
(888)
R Mehra, I Asangani, R Lonigro, X Cao, NE Philips, K Suleman, S Varambally, MA Rubin, RB Shah, KJ Pienta, AM Chinnaiyan - University of Michigan, Ann Arbor; Weill Cornell Medical College, New York; Caris Life Sciences, Irving
Does Gleason Grade Progress over Time?
(952)
MJ Stampfer, K Penney, J Sinnott, R Flavin, J Stark, S Finn, E Giovannucci, H Sesso, M Loda, L Mucci, M Fiorentino - Dana Farber/Harvard Cancer Center, Boston, MA
Do Patients with Multiple Positive Cores of Gleason Score 6 (GS6) Adenocarcinoma on Biopsy Have Unfavorable Findings at Radical Prostatectomy (RP)?
(800)
CL Ellis, JI Epstein - The Johns Hopkins Hospital, Baltimore
Potential Impact of Gleason Grade Reproducibility on Active Surveillance Management in Prostate Cancer: A Multi-Institutional Study of Patients Enrolled in a Prospective Active Surveillance Study (PASS).
(887)
JK McKenney, J Simko, M Bonham, LD True, S Hawley, L Newcomb, PASS Pathology Group, PR Carroll, JD Brooks - Stanford, Stanford, CA; University of California, San Francisco; University of Washington, Seattle; Canary Foundation, Palo Alto, CA
Global Gleason Score on Prostate Needle Biopsies as Predictor of Prostatectomy Gleason Score: Comparison with Highest Gleason Score, Greatest-Percent and Largest-Length Gleason Scores.
(946)
MM Shevchuk, A Strivastava, A Tewari - Weill Cornell Medical College, New York, NY
Focal Prostate Atrophic Lesions and Risk of Lethal Prostate Cancer.
(787)
S Davidsson, M Fiorentino, O Andren, F Fang, LA Mucci, E Varenhorst, K Fall, JR Stark - Orebro University Hospital, Orebro, Sweden; Bologna University, Italy; Brigham & Women's Hospital, Boston, MA; Harvard School of Public Health, Boston, MA; Linkoping University Hospital, Linkoping, Sweden; Karolinska Institute, Stockholm, Sweden
Does the Sextant Site of Atypical Small Acinar Proliferation on Initial Prostate Needle Biopsy Predict Sextant Site of Cancer on Follow-Up Prostate Needle Biopsy?
(890)
JL Merrimen, G Jones, A Rocker, JR Srigley - Dalhousie University, Halifax, Canada; McMaster University, Hamilton, Canada; Mount Sinai Hospital, Toronto, Canada
Initial High Grade Prostatic Intraepithelial Neoplasia (HGPIN) with Carcinoma on Subsequent Prostate Needle Biopsy: Findings at Radical Prostatectomy.
(735)
T Alhussain, J Epstein - The Johns Hopkins Hospital, Baltimore, MD
High-Grade Prostatic Intraepithelial Neoplasia (HGPIN): Preinvasive Lesion of Adenocarcinoma (CA) or Epiphenomenon? A Topographic Study of HGPIN and CA in Radical Prostatectomies (RP).
(759)
AAAV Brasil, A Billis, L Meirelles, LLL Freitas, PH Poletto, P Zubioli, WJ Favaro, VHA Cagnon, LO Reis, U Ferreira - School of Medicine, University of Campinas (Unicamp), SP, Brazil
Perineal Mapping Biopsy of Prostate: Experience from a Single Academic Institution and Impact on Prostate Cancer Management.
(865)
LP Kunju, R Siddiqui, M Rowley, D Miller, S Meyers, D Wood, JT Wei - University of Michigan, Ann Arbor
Inflammation Confined to the Stromal Compartment in Benign Prostate Biopsy May Be Associated with Decreased Risk of Subsequent Prostate Cancer (PCa).
(934)
BA Rybicki, A Rundle, D Tang, NS Gupta, DA Chitale, ON Kryvenko - Henry Ford Hospital, Detroit, MI
Risk of Prostatic Carcinoma Following a Diagnosis of Atypical Small Acinar Proliferation: A Multicenter Retro-Respective Study.
(815)
MY Gabril, B Moussa, S Metias, MS Moussa, GM Yousef - London Health Sciences Center/ University of Western Ontario, ON, Canada; St Michael's Hospital/University of Toronto, ON, Canada
Usual and Unusual Histologic Patterns of Gleason Score 8-10 Adenocarcinoma of the Prostate.
(819)
S Gottipati, JC Warncke, PA Humphrey - Washington University Medical Center, MO
The Diagnosis of Clear Cell Renal Cell Carcinoma (CRCC) on Needle Core Biopsies (NCB) of the Kidney: How Specific Is Carbonic Anhydrase IX (CA9) Immunohistochemistry (IHC)?
(821)
R Goyal, B Zhu, S Bishu, V Parimi, X Lin, XJ Yang, SM Rohan - Northwestern University Feinberg School of Medicine, Chicago, IL
Expression of Putative Stem Cell Markers CD133 and Oct-4 in Papillary Renal Cell Carcinoma and Its Prognostic Significance.
(857)
K Kim, JY Ro, YM Cho - Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Renal Cell Carcinoma with Extensive Clear Cell Component and Papillary Architecture: Value of Immunohistochemistry.
(795)
L Duan, RF Youssef, V Margulis, Y Lotan, P Koduru, W Kabbani, P Kapur - University of Texas Southwestern Medical Center, Dallas
Renal Epithelial Tumors with Clear Cell Morphology Encompass a Heterogeneous Group of Renal Cell Carcinomas.
(836)
M Hosseini, M Tretiakova, A Chang, J Taxy, T Antic - University of Chicago, IL
The Spectrum of Morphologic Findings in Clear Cell Papillary Renal Cell Carcinoma.
(974)
SR Williamson, JN Eble, L Cheng, DJ Grignon - Indiana University, Indianapolis
Renal Mucinous Tubular and Spindle Cell Carcinoma: Expanding Our Knowledge of Immunohistochemical and Cytogenetic Findings.
(870)
AR Laury, M Riveros-Angel, VS Sabbisetti, P Dal Cin, MS Hirsch - Brigham and Women's Hospital, Boston, MA
Subtyping of Papillary Renal Cell Carcinoma (PRC) by Fine Needle Aspiration (FNA): A Reliable Approach To Providing Valuable Prognostic Information.
(913)
GE Parks, SJ Sirintrapun, KR Geisinger - Wake Forest University School of Medicine, Winston-Salem, NC
Relationship between Sporadic Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) and Renal Angiomyoadenomatous Tumor (RAT) of the Kidney: Analysis by Virtual-Karyotyping, Fluorescent In Situ Analysis and Immunohistochemistry (IHC).
(751)
A Behdad, FA Monzon, O Hes, M Hirsch, M Michal, E Comperat, P Camparo, P Rao, M Picken, R Montironi, C Annaiah, LP Herrera, K Arora, DE Westfall, P Tamboli, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; The Methodist Hospital, Houston, TX; Charles University, Plzen, Czech Republic; l'Hotel-Dieu, Place du Parvis, Paris, France; Hopital Foch, Suresnes, France; Brigham and Women's Hospital, Boston, MA; MD Anderson Cancer Center, Houston, TX; Loyola University Hospital, Chicago, IL; Polytechnic University of the Marche Region, Ancona, Italy
Clear Cell Papillary Renal Cell Carcinoma and XP11.2 Translocation-Associated Renal Cell Carcinoma Are Derived from Distal Nephron Tubules and Proximal-Tubules Respectively.
(984)
PL Zhang, MB Amin - William Beaumont Hospital, Royal Oak, MI
Sporadic Hybrid Oncocytic/Chromophobe Tumor (HOCT) of the Kidney . The Quest To Define It Continues!.
(961)
K Trpkov, M Brunelli, G Martignoni, A Yilmaz - University of Calgary, AB, Canada; Universita di Verona, Verona, Italy
Renal Small Cell Oncocytoma with Pseudosettes . A Histomorphologic, Immunohistochemical, Ultrastructural and Molecular Genetic Study of 10 Cases.
(915)
FB Petersson, T Vanecek, M Michal, N Kuroda, M Hora, O Hes - Charles University and University Hospital, Plzen, Czech Republic; National University Health System, Singapore, Singapore; Red Cross Hospital, Kochi, Japan
Correlation of Recently Proposed Chromophobe Tumor Grade (CTG) with Initial Stage in 82 Chromophobe Renal Cell Carcinomas (RCC) from a Single Institution.
(970)
E Weinzierl, B Chung, J McKenney - Stanford, Stanford, CA
Epithelial p16 Expression Is Associated with Chromophobe Renal Cell Carcinomas but Not Oncocytic Renal Lesions.
(742)
V Ananthanarayanan, M Tretiakova, J Taxy, T Antic - University of Chicago, IL
Clear Cell Renal Cell Carcinoma with Tubular-Follicular-Cystic Architecture.
(860)
Z Kos, EC Belanger, SJ Robertson, B Djordjevic, KT Mai - The University of Ottawa, ON, Canada
7q31 (C-MET) Amplification Is a Constant Finding in Tubulo-Cystic Renal Cell Carcinoma.
(764)
M Brunelli, D Segala, S Gobbo, S Bersani, E Bragantini, M Gardiman, I Alvarado Cabrero, M Chilosi, G Martignoni - University of Verona, Italy; S. Chiara Hospital, Trento, Italy; Univeristy of Padua, Italy; Centro Medico, Mexico City, Mexico
Calcium Oxalate Crystals Are Present in Acquired Cystic Kidney Disease in End-Stage Renal Disease (ACKD-ESRD) but Not in Autosomal Dominant Polycystic Kidney Disease (ADPKD) . Does This Signify a Role in Cancer Development?
(919)
MM Picken, V Mehta - Loyola University Medical Center, Maywood, IL
Comparison of the Pathologic Spectrum of Neoplasia in Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Acquired Cystic Kidney Disease in End-Stage Renal Disease (ACKD-ESRD).
(918)
MM Picken, V Mehta - Loyola University Medical Center, Maywood, IL
Affymetrix Genechip Microarray Analysis of Renal Cell Carcinoma in Formalin Fixed Paraffin Embedded Tissue.
(809)
K Fisher, AN Young, Q Yin-Goen, AO Osunkoya - Emory University Scool of Medicine, Atlanta
Hedgehog Pathway Gene Product Expression in Renal Cell Carcinomas (RCC).
(858)
KA Kim, JL Garbaini, CE Sheehan, RP Kaufman, JS Ross, AM Hayner-Buchan - Albany Medical College, NY
miR-210 (Hypoxia-Responsive) a Marker of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
(965)
VA Valera Romero, BA Walter Rodriguez, M Sobel, WM Linehan, MJ Merino - National Cancer Institute, NIH, Bethesda
Renal Cell Carcinoma with Novel VCL-ALK Fusion: New Representative of ALK-Associated Tumor Spectrum.
(788)
L Debelenko, S Raimondi, N Daw, B Shivakumar, M Nelson, D Huang, J Bridge - St. Jude Children's Hospital, Memphis, TN; Nebraska Medical Center, Omaha
Renal Translocation t(6;11) Carcinoma: A Study on 5 Cases Using Histomorphology, Immunohistochemistry, Ultrastructure and Molecular Genetic Techniques.
(916)
FB Petersson, T Vanecek, M Michal, G Martignoni, M Brunelli, D Spagnolo, N Kuroda, X Yang, I Alvarado Cabrero, M Hora, O Hes - Charles University and University Hospital, Plzen, Czech Republic; National University Health System, Singapore, Singapore; University of Verona, Italy; PathWest Laboratory Medicine WA, Nedlands, Australia; Red Cross Hospital, Kochi, Japan; North West University Chicago, IL; Centro Medico, Mexico City, Mexico
Clinical Significance of miR-21 in Renal Cell Carcinoma.
(805)
H Faragalla, Y Youssef, B Kahalil, NMA White, S Mejia-Guerrero, C Streutker, M Jewett, G Bjarnason, L Sugar, MI Attalah, GM Yousef - Li Ka Shing Knowledge Institue St. Michael's Hosptial, Toronto, ON, Canada; Princess Margaret Hospital, Toronto, ON, Canada; Sunnybrook Health Sciences Center, Toronto, ON, Canada; University of Toronto, ON, Canada
microRNA Expression and mRNA Transcripts in Clear Cell (Conventional) Renal Cell Carcinoma.
(841)
AH Hughes, G Sharma, S Roy, JM Krill-Burger, CM Sciulli, MA Lyons, LA Kelly, AV Parwani, R Dhir, T McHale, WA LaFramboise, SI Bastacky - UPMC, Pittsburgh, PA
microRNA Profiling in Clear Cell Renal Cell Carcinoma: Biomarker Discover and Identification of Potential Controls and Consequences of miRNA Dysregulation.
(971)
NMA White, TT Bao, J Grigull, YM Youssef, A Girgis, M Diamandis, E Fatoohi, M Metias, RJ Honey, R Stewart, KT Pace, GA Bjarnason, GM Yousef - Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; University of Toronto, ON, Canada; York University, Toronto, ON, Canada; St. Michael's Hospital, Toronto, ON, Canada; Sunnybrook Odette Cancer Center, Toronto, ON, Canada
microRNA Profiling in Kidney Cancer: Accurate Molecular Classification of Subtypes and Correlation with Cytogenetic and mRNA Data.
(981)
YM Youssef, NMA White, J Grigull, A Krizova, C Samy, S Mejia-Guerrera, A Evans, GM Yousef - University of Toronto, ON, Canada; Li Ka Shing Knowledge Institute, Toronto, ON, Canada; York University, Toronto, ON, Canada; Toronto General Hospital, ON, Canada
Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma.
(737)
S Ali, VA Master, A Abbasi, O Kucuk, AN Young, K Ogan, JG Pattaras, PT Nieh, FF Marshall, AO Osunkoya - Emory University School of Medicine, Atlanta, GA
PAX8 Is a Sensitive Marker for Papillary Renal Cell Carcinoma: Comparison with PAX2.
(842)
A Husain, S Liu, A Yilmaz, K Trpkov - University of Calgary and Calgary Laboratory Services, AB, Canada
ALDH1 Expression Is Associated with Low Tumor Grade and Stage in Renal Cell Carcinomas (RCC).
(873)
JA Levesque, JS Ross, CE Sheehan, RP Kaufman, A Hayner-Buchan - Albany Medical College, NY
Immunohistochemical Expression of OCT 3/4 in Renal Medullary Carcinoma . A Potential Diagnostic Pitfall.
(923)
P Rao, P Tamboli - University of Texas MD Anderson Cancer Center, Houston
Invasive Urothelial Carcinomas of the Renal Pelvis Show Immunohistochemical Expression for PAX8 and PAX2 in a Subset of Cases.
(840)
J Hughes, AR Sangoi, JK McKenney - Stanford, Stanford, CA; El Camino Hospital, Mountain View, CA
Immunohistochemical Expression of Renal Markers in Matched Primary and Metastatic Renal Cell Carcinomas.
(908)
Z Pan, WE Grizzle, O Hameed - University of Alabama at Birmingham
Role of Immunohistochemistry (IHC) in the Differential Diagnosis of Invasive Urothelial Carcinoma (UCa) Versus High-Grade Tumors of the Renal Collecting System [Collecting Duct Carcinoma (CDC) and Renal Medullary Carcinoma (RMC)].
(746)
C Annaiah, GP Paner, AM Gown, C Gulmann, M Amin, AO Osunkoya, M Vankalakunti, LP Herrera, R Gupta, K Arora, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; University of Chicago, IL; PhenoPath Laboratories, Seattle, WA; William Beaumont Hospital, Detroit, MI; Emory University Hospital, Atlanta, GA
The Diagnostic Utility of CAIX, TTF-1 and TGB Immunopanel in the Diagnosis of Metastatic Renal Cell Carcinoma to the Thyroid.
(902)
G Netto, A Cimino-Mathews - The Johns Hopkins Hospital, Baltimore
Immunohistochemical (IHC) Expression of Carbonic Anhydrase IX (CA9) in Papillary (PRCC) and Chromophobe (CHRCC) Renal Cell Carcinoma Is Associated with Necrosis.
(820)
R Goyal, B Zhu, V Parimi, S Bishu, X Lin, XJ Yang, SM Rohan - Northwestern University, Chicago, IL
Gain of Chromosome 12 Is an Adverse Prognostic Factor for Clinically Localized Clear Cell Renal Cell Carcinoma: A Chromogenic In-Situ Hybridization (CISH) Study.
(828)
H He, P Elson, H Aydin, S Campbell, B Rini, C Magi-Galluzzi, R Tubbs, M Zhou - Cleveland Clinic; Peking University, Health Science Center, Beijing, China
Carbonic Anhydrase IX Is an Independent Prognostic Predictor for Clinically Localized Clear Cell Renal Cell Carcinoma.
(827)
H He, P Elson, H Aydin, S Campbell, B Rini, C Magi-Galluzzi, M Zhou - Cleveland Clinic; Peking University, Health Science Center, Beijing, China
Prognostic Significacne of MTORC1 Immunoexpression in Clear Cell (Conventional) Renal Cell Carcinoma.
(854)
P Kapur, D Rakheja, RF Yousse, V Margulis, W Kabbani, Y Lotan - UT Southwestern Medical Center, Dallas, TX
Prognostic Values of Histologic Subtype and Other Clinicopathologic Features: A Study of 961 Patients with Renal Cell Carcinomas Treated by Radical Nephrectomy.
(943)
SS Shen, JY Ro, LD Truong, AG Ayala - The Methodist Hospital and Weill Medical College of Cornell University, Houston, TX
MLH1 and PMS2 Define Prognosis in Sporadic Urothelial Carcinoma of Renal Pelvis and Ureter.
(743)
L Andres, L Zaldumbide, A Gaafar, J Gonzalez, A Garcia Tello, JC Angulo, JI Lopez - Hospital de Cruces, University of the Basque Country, Barakaldo, Spain; Hospital de Mendaro, Spain; Hospital de Getafe, Spain
Chromosomal Imbalances Identify Pathways Associated with Resistance to Antiangiogenic Therapy in Clear Cell Renal Cell Carcinoma.
(895)
FA Monzon, K Alvarez, L Peterson, K Sircar, P Tamboli, E Jonasch - The Methodist Hospital, Houston, TX; The Methodist Hospital Research Institute, Houston, TX; MD Anderson Cancer Center, Houston, TX
Clinicopathologic Characteristics and Outcomes of Renal Cell Carcinoma: A Single Center Experience.
(855)
P Kapur, R Youssef, F Alhalabi, V Margulis, Y Lotan, W Kabbani - UT Southwestern Medical Center, Dallas, TX
Histology-Radiology Correlation in Metastatic Clear Cell Renal Cell Carcinoma Treated with Pre-Operative Sorafenib and Nephrectomy.
(796)
W Dubinski, TK Kim, JJ Knox, A Finelli, AJ Evans - University Health Network, Toronto, ON, Canada
Growth Pattern: A New Prognostic Parameter of Clear Renal Cell Carcinoma.
(963)
T Tsuzuki, A Fukatsu, N Sassa, T Nishikimi, S Katsuno, T Fujita, Y Yoshino, R Hattori, M Gotoh - Nagoya Daini Red Cross Hospital, Japan; Komaki City Hospital, Japan; Nagoya University Hospital, Japan; Okazaki Municipal Hospital, Japan; Chukyo Hospital, Nagoya, Japan
Viability of Glomeruli and Proximity to Tumor in Partial Nephrectomy Specimens for Renal Cell Carcinoma.
(866)
ET Lam, A Mortazavi, GS Phillips, D Sharp, D Zynger - The Ohio State University Medical Center, Columbus
button next to any title to add to Itinerary Planner...
Add
